1Rixe O, Ortuzar W, Alvarez M, et al. Oxaliplatin, tetraplatin, Cis-platin, and carboplatin : spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute'sAnti-cancer Drug Screen panel[ J ] .Biochem Pharmacol, 1996, 52 : 1855.
3Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and molecular basis of oxaliplatin nenrotoxicity current management and development of preventive measures[J] .Semin Oncol, 2002, 29 (5 Snppll5) : 21-33.
